Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIM Doctor is a South Korean medical technology company specializing in artificial intelligence-driven diagnostic solutions for cardiovascular and neurological diseases. The company's flagship products, such as Heart-AIM, utilize deep learning algorithms to analyze medical imaging data, providing clinicians with precise assessments of coronary artery stenosis and fractional flow reserve. By integrating advanced AI into clinical workflows, AIM Doctor aims to improve the accuracy of diagnoses and optimize treatment planning for complex conditions like heart disease and stroke. The company actively collaborates with major medical institutions to validate its technology and expand its portfolio of Software as a Medical Device (SaMD). Its solutions are designed to reduce the time required for diagnosis while increasing the reliability of clinical decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIM Doctor.